Zurück zu Projekte

25390.2 PFLS-LS

Modelling and preclinical verification of a diagnostic and therapeutic approach to treat microvascular obstructions in heart attack patients.

Zusammenfassung

Modelling and preclinical verification of a diagnostic and therapeutic approach to treat microvascular obstructions in heart attack patients.

Weitere Texte

Abstract

A major cardiovascular unmet medical need today is the peri#procedural diagnosis and treatment of microvascular obstructions (MVO). MVO occurs in 40% # 60% of acute myocardial infarction with STsegment elevations patients treated with a stent. Current therapeutic options remain limited with non#standardized approaches attempting to clear the MVO#s. ReFlow Therapeutics aims at developing the first diagnostic and therapeutic medical device that can diagnose and treat MVO while the patient is still in the catheter laboratory after a stent.

Beteiligte

Dominik Obrist

Kontaktperson

dominik.obrist@artorg.unibe.ch

Universität Bern ARTORG Center Dominik Obrist Murtenstrasse 50 3008 Bern BE CH

Jon H. Hoem

Wirtschaftspartner

jhoem@reflow-therapeutics.ch

ReFlow Therapeutics AG Jon H. Hoem Neuhofstrasse 5a 6340 Baar ZG CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2017-02-28
Enddatum
2018-08-31
Bewilligte Gesamtkosten
CHF 823925.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Industrielle Produktivität und Technologie

Forschungsdisziplinen

  • T115 Medical technology 100.0%